InVivo Therapeutics Holdings Co (NVIVQ)
Jul 16, 2024 - NVIVQ was delisted (reason: shares cancelled)
0.3700
0.00 (0.00%)
Inactive · Last trade price on Jul 15, 2024

NVIVQ Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec '22 Dec '21 Dec '20 Dec '19 Dec '18
151617214
Market Cap Growth
--71.20%-8.87%701.01%-84.76%-46.70%
Enterprise Value
-7-11-2-1-3-3
PE Ratio
--0.43-1.58-1.89-0.18-0.60
PB Ratio
0.130.290.860.890.380.87
P/FCF Ratio
--0.42-1.75-1.79-0.21-1.14
P/OCF Ratio
--0.43-1.77-1.80-0.21-1.14
EV/EBITDA Ratio
-1.100.220.150.280.11
EV/EBIT Ratio
-1.050.210.150.270.11
EV/FCF Ratio
-1.020.230.140.310.20
Debt / Equity Ratio
-0.060.070.050.240.01
Debt / EBITDA Ratio
--0.10-0.14-0.12-0.120.00
Debt / FCF Ratio
--0.09-0.15-0.11-0.13-0.01
Quick Ratio
12.886.767.299.882.487.56
Current Ratio
14.307.277.339.972.557.77
Interest Coverage
-60.77-68.47-3297.33--45.57-112.70
Return on Equity (ROE)
-75.00%-77.50%-45.00%-77.90%-126.30%-228.50%
Return on Assets (ROA)
-65.00%-62.80%-40.00%-63.00%-92.70%-121.70%
Return on Invested Capital (ROIC)
-110.52%-63.79%-50.97%-45.02%-166.70%-78.76%
Earnings Yield
-811.74%-233.10%-63.32%-52.91%-552.56%-166.68%
FCF Yield
-877.10%-236.48%-57.15%-55.83%-482.31%-88.08%
Buyback Yield / Dilution
-123.21%-16.08%-379.40%-1958.36%-101.59%-278.71%
Total Shareholder Return
-123.21%-16.08%-379.40%-1958.36%-101.59%-278.71%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).